- Home
- VERU vs SLDB Comparison
VERU vs SLDB Comparison
Compare VERU & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VERU
- SLDB
- Stock Information
- Founded
- VERU 1971
- SLDB 2013
- Country
- VERU United States
- SLDB United States
- Employees
- VERU N/A
- SLDB N/A
- Industry
- VERU Biotechnology: Pharmaceutical Preparations
- SLDB Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VERU Health Care
- SLDB Health Care
- Exchange
- VERU Nasdaq
- SLDB Nasdaq
- Market Cap
- VERU 108.8M
- SLDB 124.7M
- IPO Year
- VERU 1990
- SLDB 2018
- Fundamental
- Price
- VERU $0.57
- SLDB $5.78
- Analyst Decision
- VERU Strong Buy
- SLDB Strong Buy
- Analyst Count
- VERU 4
- SLDB 12
- Target Price
- VERU $4.00
- SLDB $17.83
- AVG Volume (30 Days)
- VERU 6.2M
- SLDB 5.4M
- Earning Date
- VERU 02-13-2025
- SLDB 03-12-2025
- Dividend Yield
- VERU N/A
- SLDB N/A
- EPS Growth
- VERU N/A
- SLDB N/A
- EPS
- VERU N/A
- SLDB N/A
- Revenue
- VERU $16,886,419.00
- SLDB N/A
- Revenue This Year
- VERU N/A
- SLDB N/A
- Revenue Next Year
- VERU N/A
- SLDB N/A
- P/E Ratio
- VERU N/A
- SLDB N/A
- Revenue Growth
- VERU 22.46
- SLDB N/A
- 52 Week Low
- VERU $0.49
- SLDB $2.88
- 52 Week High
- VERU $1.92
- SLDB $15.05
- Technical
- Relative Strength Index (RSI)
- VERU 44.48
- SLDB 69.94
- Support Level
- VERU $0.49
- SLDB $3.15
- Resistance Level
- VERU $0.56
- SLDB $7.20
- Average True Range (ATR)
- VERU 0.05
- SLDB 0.63
- MACD
- VERU 0.00
- SLDB 0.37
- Stochastic Oscillator
- VERU 63.62
- SLDB 67.13
About VERU Veru Inc.
Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). The company is also in the late-stage development of certain drugs for the management of breast and prostate cancers. It also has a sexual health program that includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in a single segment and generates revenue from the USA which is the key revenue generating market, Brazil, and other regions.
About SLDB Solid Biosciences Inc.
Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.